44 results
6-K
EX-99.1
GMDAQ
Gamida Cell Ltd
21 Jul 20
Gamida Cell Announces Appointment of Michele Korfin as Chief Operating and Chief Commercial Officer
8:07am
oversight of manufacturing and commercialization as Gamida Cell advances its clinical development candidates: omidubicel, an advanced cell therapy
6-K
EX-99.1
GMDAQ
Gamida Cell Ltd
7 Jun 21
Gamida Cell Announces Appointment of Senior Vice President, Global Operations and Manufacturing and Provides Commercial Manufacturing Update
7:11am
and oversight of the company’s contract manufacturing partnership with Lonza. The scope will focus on both omidubicel and readiness for Gamida Cell’s
DEF 14A
GMDAQ
Gamida Cell Ltd
22 Jun 22
Definitive proxy
4:22pm
the independence of the Board in its oversight of our business and affairs. In addition, we believe that having an independent Chairman creates an environment … that is more conducive to objective evaluation and oversight of management’s performance, increasing management accountability and improving
PRE 14A
GMDAQ
Gamida Cell Ltd
10 Jun 22
Preliminary proxy
4:25pm
of the Board in its oversight of our business and affairs. In addition, we believe that having an independent Chairman creates an environment … that is more conducive to objective evaluation and oversight of management’s performance, increasing management accountability and improving the ability of our
F-1/A
EX-10.12
GMDAQ
Gamida Cell Ltd
17 Oct 18
Registration statement (foreign) (amended)
6:06am
) to the extent required by the Shareholder, audited, in accordance with the Public Company Accounting Oversight Board (PCAOB) rules and standards
6-K
EX-99.3
wovva3 eop
7 May 19
Current report (foreign)
1:57pm
10-K
EX-10.19
s87edyhiczowv0o
24 Mar 22
Annual report
7:30am
6-K
EX-99.2
v6o3uza0a
12 Aug 20
Report of Foreign Private Issuer
8:27am
F-1/A
gssy4t3
17 Oct 18
Registration statement (foreign) (amended)
6:06am
424B4
w6z8f9690t gf
30 Oct 18
Prospectus supplement with pricing info
8:35am
DRS/A
5bfcbhre
3 Jul 18
Draft registration statement (amended)
12:00am
F-1
py19s3y5
28 Sep 18
Registration statement (foreign)
4:29pm
DRS
e5lg4a hbgw4bg0ovy
1 Jun 18
Draft registration statement
12:00am
10-K
vabm qo2ce
24 Mar 22
Annual report
7:30am